Venous Thromboembolism

Showing 26 - 50 of 431

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose

Recruiting
  • Venous Thromboembolism
  • Prophylactic low molecular weight heparin
  • Low molecular weight heparin and low-dose aspirin
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Jan 18, 2023

Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism Trial (The multifaceted interventions, Routine VTE

Recruiting
  • Venous Thromboembolic Disease
  • +4 more
  • The multifaceted interventions
  • Routine VTE prophylaxis
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Jan 19, 2023

Examining the Experiences of Children With Blood Disorders

Recruiting
  • Blood Disease
  • +4 more
    • Dallas, Texas
      The University of Texas Southwestern Medical Center
    Jan 16, 2023

    Glioblastoma, Astrocytoma, Venous Thromboembolism Trial (Apixaban)

    Not yet recruiting
    • Glioblastoma
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Achilles Tendon Rupture, Ankle Fractures, Venous Thromboembolism Trial in Stockholm (Adjuvant IPC)

    Recruiting
    • Achilles Tendon Rupture
    • +2 more
    • Adjuvant IPC
    • Stockholm, Sweden
      Karolinska University Hospital
    Jan 3, 2023

    Venous Thromboembolism, Arthroplasty Trial in Chiayi City (Rivaroxaban 10 MG)

    Recruiting
    • Venous Thromboembolism
    • Arthroplasty
    • Rivaroxaban 10 MG
    • Chiayi City, Taiwan
      Ditmanson Medical Foundation Chiayi Christian Hospital
    Dec 20, 2022

    Evaluation of the SCALED (SCaling AcceptabLE cDs)

    Not yet recruiting
    • Traumatic Brain Injury
    • Venous Thromboembolism
    • Observational
    • Observational-control
    • (no location specified)
    Nov 16, 2022

    Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)

    Terminated
    • Venous Thromboembolism
    • Lung Neoplasm
    • Tinzaparin Sodium
    • Rennes, Bretagne, France
    • +26 more
    Nov 14, 2022

    Venous Thromboembolism Trial (REGN9933, Enoxaparin, Apixiban)

    Not yet recruiting
    • Venous Thromboembolism
    • (no location specified)
    Nov 8, 2022

    Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Thromboembolisms Trial in Philadelphia (OsciPulse)

    Completed
    • Venous Thromboembolism
    • +2 more
    • OsciPulse
    • Philadelphia, Pennsylvania
      Penn Presbyterian Medical Center
    Nov 2, 2022

    Anticoagulation Length of ThErapy and Risk of New Adverse evenTs

    Completed
    • Venous Thromboembolism
    • Anticoagulants and Bleeding Disorders
    • Oral Anticoagulant
    • Oakland, California
    • +1 more
    Oct 31, 2022

    COVID-19 and Venous Thromboembolism Risk

    Completed
    • Venous Thromboembolism
    • Covid19
    • Laboratory test positive for SARS-CoV-2 virus
    • Oakland, California
    • +1 more
    Oct 31, 2022

    Xarelto for Venous Thromboembolism (VTE)

    Completed
    • Venous Thromboembolism
    • Rivaroxaban (Xarelto, BAY59-7939)
    • Multiple Locations, Japan
      Many locations
    Oct 30, 2022

    Venous Thromboembolism Trial in Valhalla (Apixaban)

    Completed
    • Venous Thromboembolism
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Enoxaparin in Hospitalized COVID-19 Patients

    Recruiting
    • Venous Thromboembolism
      • Richardson, Texas
        Methodist Richardson Medical Center
      Oct 21, 2022

      DOAC in Chinese Patients With Atrial Fibrillation

      Recruiting
      • Atrial Fibrillation
      • +6 more
      • Blood Tests
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      Oct 11, 2022

      Venous Thromboembolism, Ovarian Cancer Trial in Sarasota, Durham (Aspirin)

      Completed
      • Venous Thromboembolism
      • Ovarian Cancer
      • Sarasota, Florida
      • +1 more
      Sep 6, 2022

      Thrombosis in Multiple Myeloma in an University Medical Center

      Recruiting
      • Multiple Myeloma
      • +2 more
      • Multiple myeloma
      • Groningen, Netherlands
        University Medical Center Groningen
      Sep 12, 2022

      Europe Based on Medical Records That Looks at Safety of

      Not yet recruiting
      • Venous Thromboembolism
      • Dabigatran Etexilate (DE)
      • (no location specified)
      Sep 9, 2022

      IBD, Venous Thromboembolism, Crohn Disease Trial in Hamilton (Apixaban 2.5 milligram, Placebo Oral Tablet)

      Recruiting
      • IBD
      • +5 more
      • Apixaban 2.5 milligram
      • Placebo Oral Tablet
      • Hamilton, Ontario, Canada
      • +1 more
      Aug 26, 2022

      Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin

      Completed
      • Venous Thromboembolism
      • +3 more
      • Rivaroxaban 20 MG [Xarelto]
      • +2 more
      • Metepec, Estado De Mexico, Mexico
        Instituto Mexicano Del Seguro Social
      Aug 24, 2022

      Venous Thromboembolism, Critical Illness Trial

      Active, not recruiting
      • Venous Thromboembolism
      • Critical Illness
        • (no location specified)
        Aug 11, 2022

        Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation Trial in Ann Arbor (New-prescription Alert, New-prescription

        Recruiting
        • Pulmonary Embolism
        • +2 more
        • New-prescription Alert
        • +3 more
        • Ann Arbor, Michigan
          University of Michigan
        Aug 3, 2022

        Venous Thromboembolism Trial in Worldwide (Apixaban, Standard of Care)

        Recruiting
        • Venous Thromboembolism
        • Birmingham, Alabama
        • +127 more
        Aug 3, 2022

        Efficacy of ICU-VTE Scale in ICU Patients

        Recruiting
        • Venous Thromboembolism
          • Wuhan, Hubei, China
            The Central Hospital of Wuhan
          Aug 2, 2022